Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, Acquiring Remaining Share of PerkinElmer India, Plans More Regional Growth

NEW YORK (GenomeWeb News) — PerkinElmer yesterday said it has acquired the remaining interest in PerkinElmer India from Labindia Instruments for an undisclosed sum.
 
The company also said it plans to open a new headquarters and a new technical support and applications center in Mumbai later this year.
 
PerkinElmer India is a sales, service, and marketing branch aimed at India’s biotechnology sector. The acquisition makes PerkinElmer India a wholly owned PerkinElmer subsidiary, the company said.
  
PerkinElmer CEO Gregory Summe said this deal shows the company’s commitment “to accelerate growth in the country’s rapidly expanding health sciences market.”
 
PerkinElmer India currently employs 170 people.
 
Financial terms of the deal were not disclosed.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.